United States
Germany
Japan
United Kingdom
China
USP44 mouse monoclonal antibody, clone OTI1D1 (formerly 1D1)
| Applications | IHC, WB |
| Reactivities | Human |
Antibodies
USP44 mouse monoclonal antibody, clone OTI1D1 (formerly 1D1)
| Applications | IHC, WB |
| Reactivities | Human |
USP44 mouse monoclonal antibody, clone OTI1A9 (formerly 1A9)
| Applications | IHC, WB |
| Reactivities | Human |
USP44 mouse monoclonal antibody, clone OTI1A9 (formerly 1A9)
| Applications | IHC, WB |
| Reactivities | Human |
USP44 mouse monoclonal antibody, clone OTI5B8 (formerly 5B8)
| Applications | WB |
| Reactivities | Human |
USP44 mouse monoclonal antibody, clone OTI1C2 (formerly 1C2)
| Applications | WB |
| Reactivities | Human |
USP44 mouse monoclonal antibody, clone OTI4E8 (formerly 4E8)
| Applications | WB |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) USP44 mouse monoclonal antibody, clone OTI5B8 (formerly 5B8)
| Applications | WB |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) USP44 mouse monoclonal antibody, clone OTI4E8 (formerly 4E8)
| Applications | WB |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) USP44 mouse monoclonal antibody, clone OTI1C2 (formerly 1C2)
| Applications | WB |
| Reactivities | Human |
USP44 mouse monoclonal antibody, clone OTI1C2 (formerly 1C2)
| Applications | WB |
| Reactivities | Human |
USP44 mouse monoclonal antibody, clone OTI5B8 (formerly 5B8)
| Applications | WB |
| Reactivities | Human |
USP44 mouse monoclonal antibody, clone OTI4E8 (formerly 4E8)
| Applications | WB |
| Reactivities | Human |
